 | • レポートコード：QYR2104Z2235 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、てんかん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ファーストジェネレーション、セカンドジェネレーション）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・てんかん治療の市場動向 ・企業の競争状況、市場シェア ・てんかん治療の種類別市場規模（ファーストジェネレーション、セカンドジェネレーション） ・てんかん治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・てんかん治療の北米市場規模2016-2027（アメリカ、カナダ） ・てんかん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・てんかん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・てんかん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・てんかん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、GlaxoSmithKline Plc、UCB、Cephalon、Johnson & Johnson、Pfizer、Novartis AG、Abbvie、Janssen Pharmaceuticals、Sunovion Pharmaceuticals、Bausch Health、Sanofi S.A、Takeda、Eisai、F. Hoffmann-La Roche） ・結論 |
Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.
In terms of geography, the Americas led the global epilepsy therapeutic market and is likely to hold close to 50% of the revenue market shares. The growth of this market in the region is due to the high prevalence of the disorder and the availability of treatment options in the region, especially in the developed markets such as the US and Canada.
Market Analysis and Insights: Global Epilepsy Therapeutic Market
The global Epilepsy Therapeutic market size is projected to reach US$ 5065.2 million by 2026, from US$ 4064.1 million in 2019, at a CAGR of 3.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epilepsy Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epilepsy Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epilepsy Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epilepsy Therapeutic market.
Global Epilepsy Therapeutic Scope and Market Size
Epilepsy Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
First Generation
Second Generation
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
GlaxoSmithKline Plc
UCB
Cephalon
Johnson & Johnson
Pfizer
Novartis AG
Abbvie
Janssen Pharmaceuticals
Cephalon
Johnson & Johnson
Sanofi S.A
Takeda
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epilepsy Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 First Generation
1.2.3 Second Generation
1.3 Market by Application
1.3.1 Global Epilepsy Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Epilepsy Therapeutic Market Perspective (2016-2027)
2.2 Epilepsy Therapeutic Growth Trends by Regions
2.2.1 Epilepsy Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epilepsy Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Epilepsy Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Epilepsy Therapeutic Industry Dynamic
2.3.1 Epilepsy Therapeutic Market Trends
2.3.2 Epilepsy Therapeutic Market Drivers
2.3.3 Epilepsy Therapeutic Market Challenges
2.3.4 Epilepsy Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epilepsy Therapeutic Players by Revenue
3.1.1 Global Top Epilepsy Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Epilepsy Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Epilepsy Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epilepsy Therapeutic Revenue
3.4 Global Epilepsy Therapeutic Market Concentration Ratio
3.4.1 Global Epilepsy Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Therapeutic Revenue in 2020
3.5 Epilepsy Therapeutic Key Players Head office and Area Served
3.6 Key Players Epilepsy Therapeutic Product Solution and Service
3.7 Date of Enter into Epilepsy Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epilepsy Therapeutic Breakdown Data by Type
4.1 Global Epilepsy Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Epilepsy Therapeutic Forecasted Market Size by Type (2022-2027)
5 Epilepsy Therapeutic Breakdown Data by Application
5.1 Global Epilepsy Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Epilepsy Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Epilepsy Therapeutic Market Size (2016-2027)
6.2 North America Epilepsy Therapeutic Market Size by Type
6.2.1 North America Epilepsy Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Epilepsy Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Epilepsy Therapeutic Market Size by Type (2016-2027)
6.3 North America Epilepsy Therapeutic Market Size by Application
6.3.1 North America Epilepsy Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Epilepsy Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Epilepsy Therapeutic Market Size by Application (2016-2027)
6.4 North America Epilepsy Therapeutic Market Size by Country
6.4.1 North America Epilepsy Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Epilepsy Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Epilepsy Therapeutic Market Size (2016-2027)
7.2 Europe Epilepsy Therapeutic Market Size by Type
7.2.1 Europe Epilepsy Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Epilepsy Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Epilepsy Therapeutic Market Size by Type (2016-2027)
7.3 Europe Epilepsy Therapeutic Market Size by Application
7.3.1 Europe Epilepsy Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Epilepsy Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Epilepsy Therapeutic Market Size by Application (2016-2027)
7.4 Europe Epilepsy Therapeutic Market Size by Country
7.4.1 Europe Epilepsy Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Epilepsy Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Epilepsy Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Epilepsy Therapeutic Market Size by Type
8.2.1 Asia-Pacific Epilepsy Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epilepsy Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epilepsy Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Epilepsy Therapeutic Market Size by Application
8.3.1 Asia-Pacific Epilepsy Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epilepsy Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epilepsy Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Epilepsy Therapeutic Market Size by Region
8.4.1 Asia-Pacific Epilepsy Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epilepsy Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Epilepsy Therapeutic Market Size (2016-2027)
9.2 Latin America Epilepsy Therapeutic Market Size by Type
9.2.1 Latin America Epilepsy Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Epilepsy Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Epilepsy Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Epilepsy Therapeutic Market Size by Application
9.3.1 Latin America Epilepsy Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Epilepsy Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Epilepsy Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Epilepsy Therapeutic Market Size by Country
9.4.1 Latin America Epilepsy Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Epilepsy Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epilepsy Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Epilepsy Therapeutic Market Size by Type
10.2.1 Middle East & Africa Epilepsy Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epilepsy Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epilepsy Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Epilepsy Therapeutic Market Size by Application
10.3.1 Middle East & Africa Epilepsy Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epilepsy Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epilepsy Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Epilepsy Therapeutic Market Size by Country
10.4.1 Middle East & Africa Epilepsy Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epilepsy Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Epilepsy Therapeutic Introduction
11.1.4 Abbott Laboratories Revenue in Epilepsy Therapeutic Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Epilepsy Therapeutic Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Epilepsy Therapeutic Business (2016-2021)
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 UCB
11.3.1 UCB Company Details
11.3.2 UCB Business Overview
11.3.3 UCB Epilepsy Therapeutic Introduction
11.3.4 UCB Revenue in Epilepsy Therapeutic Business (2016-2021)
11.3.5 UCB Recent Development
11.4 Cephalon
11.4.1 Cephalon Company Details
11.4.2 Cephalon Business Overview
11.4.3 Cephalon Epilepsy Therapeutic Introduction
11.4.4 Cephalon Revenue in Epilepsy Therapeutic Business (2016-2021)
11.4.5 Cephalon Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Epilepsy Therapeutic Introduction
11.5.4 Johnson & Johnson Revenue in Epilepsy Therapeutic Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Epilepsy Therapeutic Introduction
11.6.4 Pfizer Revenue in Epilepsy Therapeutic Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Epilepsy Therapeutic Introduction
11.7.4 Novartis AG Revenue in Epilepsy Therapeutic Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Abbvie
11.8.1 Abbvie Company Details
11.8.2 Abbvie Business Overview
11.8.3 Abbvie Epilepsy Therapeutic Introduction
11.8.4 Abbvie Revenue in Epilepsy Therapeutic Business (2016-2021)
11.8.5 Abbvie Recent Development
11.9 Janssen Pharmaceuticals
11.9.1 Janssen Pharmaceuticals Company Details
11.9.2 Janssen Pharmaceuticals Business Overview
11.9.3 Janssen Pharmaceuticals Epilepsy Therapeutic Introduction
11.9.4 Janssen Pharmaceuticals Revenue in Epilepsy Therapeutic Business (2016-2021)
11.9.5 Janssen Pharmaceuticals Recent Development
11.10 Sunovion Pharmaceuticals
11.10.1 Sunovion Pharmaceuticals Company Details
11.10.2 Sunovion Pharmaceuticals Business Overview
11.10.3 Sunovion Pharmaceuticals Epilepsy Therapeutic Introduction
11.10.4 Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutic Business (2016-2021)
11.10.5 Sunovion Pharmaceuticals Recent Development
11.11 Bausch Health
11.11.1 Bausch Health Company Details
11.11.2 Bausch Health Business Overview
11.11.3 Bausch Health Epilepsy Therapeutic Introduction
11.11.4 Bausch Health Revenue in Epilepsy Therapeutic Business (2016-2021)
11.11.5 Bausch Health Recent Development
11.12 Sanofi S.A
11.12.1 Sanofi S.A Company Details
11.12.2 Sanofi S.A Business Overview
11.12.3 Sanofi S.A Epilepsy Therapeutic Introduction
11.12.4 Sanofi S.A Revenue in Epilepsy Therapeutic Business (2016-2021)
11.12.5 Sanofi S.A Recent Development
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Epilepsy Therapeutic Introduction
11.13.4 Takeda Revenue in Epilepsy Therapeutic Business (2016-2021)
11.13.5 Takeda Recent Development
11.14 Eisai
11.14.1 Eisai Company Details
11.14.2 Eisai Business Overview
11.14.3 Eisai Epilepsy Therapeutic Introduction
11.14.4 Eisai Revenue in Epilepsy Therapeutic Business (2016-2021)
11.14.5 Eisai Recent Development
11.15 F. Hoffmann-La Roche
11.15.1 F. Hoffmann-La Roche Company Details
11.15.2 F. Hoffmann-La Roche Business Overview
11.15.3 F. Hoffmann-La Roche Epilepsy Therapeutic Introduction
11.15.4 F. Hoffmann-La Roche Revenue in Epilepsy Therapeutic Business (2016-2021)
11.15.5 F. Hoffmann-La Roche Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Epilepsy Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of First Generation
Table 3. Key Players of Second Generation
Table 4. Global Epilepsy Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Epilepsy Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Epilepsy Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Epilepsy Therapeutic Market Share by Regions (2016-2021)
Table 8. Global Epilepsy Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Epilepsy Therapeutic Market Share by Regions (2022-2027)
Table 10. Epilepsy Therapeutic Market Trends
Table 11. Epilepsy Therapeutic Market Drivers
Table 12. Epilepsy Therapeutic Market Challenges
Table 13. Epilepsy Therapeutic Market Restraints
Table 14. Global Epilepsy Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Epilepsy Therapeutic Market Share by Players (2016-2021)
Table 16. Global Top Epilepsy Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Therapeutic as of 2020)
Table 17. Ranking of Global Top Epilepsy Therapeutic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Epilepsy Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Epilepsy Therapeutic Product Solution and Service
Table 21. Date of Enter into Epilepsy Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Epilepsy Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Epilepsy Therapeutic Revenue Market Share by Type (2016-2021)
Table 25. Global Epilepsy Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Epilepsy Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Epilepsy Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Epilepsy Therapeutic Revenue Market Share by Application (2016-2021)
Table 29. Global Epilepsy Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Epilepsy Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Epilepsy Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Epilepsy Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Epilepsy Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Epilepsy Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Epilepsy Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Epilepsy Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Epilepsy Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Epilepsy Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Epilepsy Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Epilepsy Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Epilepsy Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Epilepsy Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Epilepsy Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Epilepsy Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Epilepsy Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Epilepsy Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Epilepsy Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Epilepsy Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Epilepsy Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Epilepsy Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Epilepsy Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Epilepsy Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Epilepsy Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Epilepsy Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Epilepsy Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Epilepsy Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Epilepsy Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Epilepsy Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Epilepsy Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Epilepsy Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Epilepsy Therapeutic Product
Table 64. Abbott Laboratories Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. GlaxoSmithKline Plc Company Details
Table 67. GlaxoSmithKline Plc Business Overview
Table 68. GlaxoSmithKline Plc Epilepsy Therapeutic Product
Table 69. GlaxoSmithKline Plc Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Plc Recent Development
Table 71. UCB Company Details
Table 72. UCB Business Overview
Table 73. UCB Epilepsy Therapeutic Product
Table 74. UCB Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 75. UCB Recent Development
Table 76. Cephalon Company Details
Table 77. Cephalon Business Overview
Table 78. Cephalon Epilepsy Therapeutic Product
Table 79. Cephalon Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 80. Cephalon Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Epilepsy Therapeutic Product
Table 84. Johnson & Johnson Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Epilepsy Therapeutic Product
Table 89. Pfizer Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Novartis AG Company Details
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Epilepsy Therapeutic Product
Table 94. Novartis AG Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 95. Novartis AG Recent Development
Table 96. Abbvie Company Details
Table 97. Abbvie Business Overview
Table 98. Abbvie Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 99. Abbvie Recent Development
Table 100. Janssen Pharmaceuticals Company Details
Table 101. Janssen Pharmaceuticals Business Overview
Table 102. Janssen Pharmaceuticals Epilepsy Therapeutic Product
Table 103. Janssen Pharmaceuticals Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 104. Janssen Pharmaceuticals Recent Development
Table 105. Sunovion Pharmaceuticals Company Details
Table 106. Sunovion Pharmaceuticals Business Overview
Table 107. Sunovion Pharmaceuticals Epilepsy Therapeutic Product
Table 108. Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 109. Sunovion Pharmaceuticals Recent Development
Table 110. Bausch Health Company Details
Table 111. Bausch Health Business Overview
Table 112. Bausch Health Epilepsy Therapeutic Product
Table 113. Bausch Health Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 114. Bausch Health Recent Development
Table 115. Sanofi S.A Company Details
Table 116. Sanofi S.A Business Overview
Table 117. Sanofi S.A Epilepsy Therapeutic Product
Table 118. Sanofi S.A Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 119. Sanofi S.A Recent Development
Table 120. Takeda Company Details
Table 121. Takeda Business Overview
Table 122. Takeda Epilepsy Therapeutic Product
Table 123. Takeda Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 124. Takeda Recent Development
Table 125. Eisai Company Details
Table 126. Eisai Business Overview
Table 127. Eisai Epilepsy Therapeutic Product
Table 128. Eisai Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 129. Eisai Recent Development
Table 130. F. Hoffmann-La Roche Company Details
Table 131. F. Hoffmann-La Roche Business Overview
Table 132. F. Hoffmann-La Roche Epilepsy Therapeutic Product
Table 133. F. Hoffmann-La Roche Revenue in Epilepsy Therapeutic Business (2016-2021) & (US$ Million)
Table 134. F. Hoffmann-La Roche Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epilepsy Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. First Generation Features
Figure 3. Second Generation Features
Figure 4. Global Epilepsy Therapeutic Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Epilepsy Therapeutic Report Years Considered
Figure 9. Global Epilepsy Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Epilepsy Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Epilepsy Therapeutic Market Share by Regions: 2020 VS 2027
Figure 12. Global Epilepsy Therapeutic Market Share by Regions (2022-2027)
Figure 13. Global Epilepsy Therapeutic Market Share by Players in 2020
Figure 14. Global Top Epilepsy Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Therapeutic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Epilepsy Therapeutic Revenue in 2020
Figure 16. Global Epilepsy Therapeutic Revenue Market Share by Type (2016-2021)
Figure 17. Global Epilepsy Therapeutic Revenue Market Share by Type (2022-2027)
Figure 18. North America Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Epilepsy Therapeutic Market Share by Type (2016-2027)
Figure 20. North America Epilepsy Therapeutic Market Share by Application (2016-2027)
Figure 21. North America Epilepsy Therapeutic Market Share by Country (2016-2027)
Figure 22. United States Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Epilepsy Therapeutic Market Share by Type (2016-2027)
Figure 26. Europe Epilepsy Therapeutic Market Share by Application (2016-2027)
Figure 27. Europe Epilepsy Therapeutic Market Share by Country (2016-2027)
Figure 28. Germany Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Epilepsy Therapeutic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Epilepsy Therapeutic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Epilepsy Therapeutic Market Share by Region (2016-2027)
Figure 38. China Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Epilepsy Therapeutic Market Share by Type (2016-2027)
Figure 46. Latin America Epilepsy Therapeutic Market Share by Application (2016-2027)
Figure 47. Latin America Epilepsy Therapeutic Market Share by Country (2016-2027)
Figure 48. Mexico Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Epilepsy Therapeutic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Epilepsy Therapeutic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Epilepsy Therapeutic Market Share by Country (2016-2027)
Figure 54. Turkey Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Epilepsy Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 58. GlaxoSmithKline Plc Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 59. UCB Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 60. Cephalon Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 64. Abbvie Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 65. Janssen Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 66. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 67. Bausch Health Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 68. Sanofi S.A Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 69. Takeda Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 70. Eisai Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 71. F. Hoffmann-La Roche Revenue Growth Rate in Epilepsy Therapeutic Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のてんかん治療市場 2021：企業別、地域別、種類・用途別 The Epilepsy Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界のてんかん治療薬市場規模・現状・予測（2021年-2027年） Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…
- 世界のてんかん治療薬市場 2021：企業別、地域別、種類・用途別 The Epilepsy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界のてんかん治療市場規模・現状・予測（2021年-2027年） Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characterized by brief and undetectable episodes of involuntary movement involving either a body part (partial) or the entire body (generalized). Neurological disorders treatment market is growing at a significant …
- 世界の眼科治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 22640 million by 2026, from US$ 15860 million in 2019, at a CAGR of 5.2% during 2021-2026. With industry-standard accuracy in analysis and high data …